Drug recall · January 8, 2014
Niacin Extended Release Tablets recall
Why: Failed Tablet/Capsule Specifications: There is a potential for broken tablets.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Niacin Extended Release Tablets, USP, 500 mg, 90 count bottle, Rx Only, Teva Pharmaceuticals USA, Inc., Sellersville, PA, 18960, NDC 0093-7392-98
- Lots / codes
Lot#: 32900349B, Exp: 12/2014
- Quantity
- 10,512 bottles
- Company
- Teva Pharmaceuticals USA, Horsham, PA
- Distribution
- Nationwide and Puerto Rico, American Samoa, Virgin Islands, and Canal Zone
- Initiated
- November 26, 2013 · Voluntary: Firm initiated
- Classified
- January 2, 2014
- Reported
- January 8, 2014
- Ended
- August 27, 2014
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Niacin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.